Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · IEX Real-Time Price · USD
4.860
-0.240 (-4.71%)
At close: Jul 2, 2024, 4:00 PM
4.940
+0.080 (1.65%)
After-hours: Jul 2, 2024, 4:40 PM EDT

Champions Oncology Cash Flow Statement

Millions USD. Fiscal year is May - Apr.
Year
20232022202120202019 2018 - 2006
Net Income
-5.340.550.36-2.090.13
Upgrade
Depreciation & Amortization
2.251.631.180.830.61
Upgrade
Share-Based Compensation
0.860.910.60.60.64
Upgrade
Other Operating Activities
6.23.41-3.833.570.49
Upgrade
Operating Cash Flow
3.976.5-1.682.911.86
Upgrade
Operating Cash Flow Growth
-38.86%--56.02%-
Upgrade
Capital Expenditures
-2.87-2.38-3.28-2.22-0.83
Upgrade
Acquisitions
000.1100
Upgrade
Investing Cash Flow
-2.87-2.38-3.17-2.22-0.83
Upgrade
Share Issuance / Repurchase
0.010.211.374.461.47
Upgrade
Debt Issued / Paid
00-0.17-0.04-0.26
Upgrade
Financing Cash Flow
0.010.211.24.421.2
Upgrade
Net Cash Flow
1.114.32-3.665.112.23
Upgrade
Free Cash Flow
1.14.11-4.960.691.03
Upgrade
Free Cash Flow Growth
-73.26%---33.37%-
Upgrade
Free Cash Flow Margin
2.04%8.38%-12.09%2.13%3.80%
Upgrade
Free Cash Flow Per Share
0.080.31-0.380.060.09
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).